OTC AMERICA INC /CO/
NT 10-Q, 1999-11-15
MANAGEMENT SERVICES
Previous: FIRST ENTERTAINMENT HOLDING CORP, 10QSB, 1999-11-15
Next: CONTINUCARE CORP, NT 10-Q, 1999-11-15



                    U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                                                   SEC FILE NUMBER 0-15992
                                                   CUSIP NUMBER 671048106

(Check One):

[ ] Form 10-K and Form 10-KSB        [ ] Form 20-F        [ ] Form 11-K
[X] Form 10-Q and Form 10-QSB        [ ] Form N-SAR

For Period Ended: September 30, 1999


For the Transition Period Ended:

     Nothing in this form shall be  construed to imply that the  Commission  has
verified any information contained herein.

     If the  notification  relates  to a portion of the  filing  checked  above,
identify the Item(s) to which the notification relates:

Part I - Registrant Information

Full Name of Registrant: OTC America, Inc.

Former Name if Applicable: N/A

Address of Principal Executive Office (Street and Number):

         600 17th Street, Suite 950 South
         Denver, CO 80202

Part II - Rules 12b-25(b) and (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate) [X]

[  ]      (a) The  reasons  described  in  reasonable  detail in Part II of this
          form could  not be eliminated  without unreasonable effort or expense;

[  ]      (b) The subject  annual  report, semi-annual report, transition report
          on Form 10-K,  Form 20-F, Form 11-K, or Form N-SAR, or portion thereof
          will be filed on or before the  fifteenth  calendar day  following the
          prescribed  due date;  or the subject  quarterly  report or transition
          report on Form 10-Q, or portion thereof will be filed on or before the
          fifth calendar day following the prescribed due date; and

[  ]      (c)  The  accountant's  statement  or other  exhibit  required by Rule
          12b-25(c) has been attached if applicable.

Part III - Narrative  State below in reasonable  detail the reasons why the Form
10-Q could not be filed within the prescribed time period.  (Attach Extra Sheets
If Needed)

"The registrant's  sole officer was unable to provide the necessary  information
to the accountants as a result of his travel schedule."


<PAGE>


Part IV - Other Information

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
notification:

         Randy Phillips
         (303) 260-6482

(2) Have all other  periodic  reports  required under section 13 or 15(d) of the
Securities  Exchange Act of 1934 or section 30 of the Investment  Company Act of
1940  during  the  preceding  12  months  or for such  shorter  period  that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s). [X] Yes [ ] No

(3) Is it anticipated that any significant  change in results of operations from
the  corresponding  period for the last  fiscal  year will be  reflected  by the
earnings statements to be included in the subject report or portion thereof? [ ]
Yes [X] No

If so, attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.






<PAGE>


                                OTC America, Inc.
                  --------------------------------------------
                  (Name of Registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.


Date: November 15, 1999              By: /s/ Randy Phillips
                                      --------------------------------------
                                      Randy Phillips, President






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission